Finanzen von Alignment Healthcare, Inc. (ALHC)ALHCAlignment Healthcare, Inc.

Evaluating the bottom line, Alignment Healthcare, Inc. maintains a gross margin of 12.96%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.15%, while the net margin is 2.74%. These profitability ratios, combined with a Return on Equity (ROE) of 20.04%, provide a clear picture of how effectively ALHC converts its operational activities into shareholder value.

In the context of the broader market, ALHC competes directly with industry leaders such as MOH and OSCR. With a market capitalization of $1.68B, it holds a significant position in the sector. When comparing efficiency, ALHC's gross margin of 12.96% stands against MOH's 12.82% and OSCR's N/A. Such benchmarking helps identify whether Alignment Healthcare, Inc. is trading at a premium or discount relative to its financial performance.

The company has shown a positive trend in net income, with a reported net income of $36,560,000 in Q2 2026, but it is still recovering from previous losses. The gross margin has improved to 12.96% in Q2 2026, but the overall financial health remains concerning with a high debt-to-equity ratio of 122.22%.